GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

RVSB · Dec 31, 2025

RIVERVIEW BANCORP INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001041368-26-000003Bank
Sequential deposit growth55thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

-0.23% · CORE · VALID

Net-income growth70thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

11.77% · CORE · VALID

Interest-income growth55thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_income

5.56% · CORE · VALID

Cash and equivalents25thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$28.6M · CORE · VALID

Sequential loan growth65thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.loans

1.43% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History58 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Decreased
Previous
2.19%
Current
-0.23%
Delta
-2.43%
Earnings Growth Increased
Previous
-29.42%
Current
11.77%
Delta
41.19%
Interest Income Growth Increased
Previous
2.88%
Current
5.56%
Delta
2.68%
Liquidity Decreased
Previous
$32.8M
Current
$28.6M
Delta
-$4.2M
Loan Growth Increased
Previous
0.20%
Current
1.43%
Delta
1.23%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.